Systematic review of surgical treatment of subclinical Cushing's syndrome.

Author: BoscaroM, CittonM, IacoboneM, NittiD, ScarpaM, VielG

Paper Details 
Original Abstract of the Article :
Subclinical Cushing's syndrome (SCS) is a condition of biochemical cortisol excess without the classical clinical features of overt hypercortisolism; it may be associated with some consequences of metabolic syndrome. The most appropriate treatment remains controversial. This study aimed to assess th...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/bjs.9742

データ提供:米国国立医学図書館(NLM)

Surgical Treatment for Subclinical Cushing's Syndrome: A Systematic Review

Cushing's syndrome, a condition caused by excess cortisol production, can have significant health consequences. This research explores the surgical treatment of subclinical Cushing's syndrome (SCS), a milder form of the disease without the classic clinical features. The study systematically reviews the outcomes of adrenalectomy, a surgical procedure to remove the adrenal gland, for SCS, aiming to assess its effectiveness and identify potential benefits and risks.

Adrenalectomy: A Potential Treatment for SCS

The study found that adrenalectomy can be an effective treatment for SCS, leading to improvements in biochemical markers and reducing the risk of developing overt Cushing's syndrome. However, the study also acknowledges that the optimal treatment for SCS remains under debate, and further research is needed to fully understand the long-term outcomes of adrenalectomy.

Weighing the Benefits and Risks of Adrenalectomy

This research emphasizes the importance of carefully evaluating the benefits and risks of adrenalectomy for SCS. The study provides valuable insights for healthcare professionals and patients considering surgical intervention for this condition.

Dr. Camel's Conclusion

The quest for the best treatment for subclinical Cushing's syndrome is like searching for a rare desert flower. This research provides a comprehensive review of adrenalectomy, highlighting its potential benefits and risks. Further research is needed to refine our understanding of this treatment option and guide optimal patient care.

Date :
  1. Date Completed 2015-04-15
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

25640696

DOI: Digital Object Identifier

10.1002/bjs.9742

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.